Biomarker discovery 

Advance your project with our biomarker discovery expertise

Our dedicated team works to identify and validate pharmacodynamic, target engagement and selection biomarkers using preclinical in vitro and in vivo models, tailored to your needs. We profile the clinical indication space with our tissue biobank to pinpoint patient populations relevant to your research. By leveraging biomarkers, we provide valuable insights into the pharmacokinetic/ pharmacodynamic (PK/PD) relationship of novel drug candidates. Additionally, we analyse biomarkers from your clinical trial samples to help ensure seamless translation of preclinical findings to clinical applications.

Precision medicine enabled

We offer integrated biomarker services, covering the entire drug discovery value chain—from preclinical biomarker discovery and validation to robust assay development, indication space population profiling and biomarker analysis of clinical samples. Our experienced biomarker scientists, with a decade-long background in the pharma industry, bring extensive knowledge across various therapeutic areas and modalities. We have a proven track record of successfully translating your drug discovery programs into clinical applications, ensuring your research progresses smoothly and effectively.

Análisis de roca entera

El análisis de roca completa determina los principales óxidos formadores de roca mediante la descomposición por fusión seguida de un análisis mediante un instrumento XRF o ICP-AES. El uso de la fusión para descomponer la muestra es garantizar que todos los minerales se descomponen por completo. Ofrecemos distintos métodos para el análisis de elementos de formación de rocas, oligoelementos o ambos en un solo paquete.

MÁS INFORMACIÓN